Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduce
暂无分享,去创建一个
N. Geller | P. Hari | D. Porter | M. Pasquini | M. Horowitz | Richard J. Jones | J. Pidala | J. Bolaños-Meade | J. Liesveld | Y. Efebera | Yi-Bin Chen | M. MacMillan | Juan Wu | D. Weisdorf | B. Logan | A. Alousi | M. Mielcarek | R. Sobecks | L. Damon | S. Giralt | S. Solomon | R. Reshef | J. Antin | D. Jacobsohn | S. Arai | S. Abhyankar | P. Noel | S. Holtan | I. Pusic | M. Fei | Z. Al-Kadhimi | J. Koreth | R. Fraser | K. Bickett | J. Bolaños-Meade